Acorn Cardiovascular set back by US rejection of heart failure "wrap" device
This article was originally published in Clinica
A novel mesh wrap designed to support the oversized and dilated hearts of people with advancing heart failure has been found not ready for marketing in the US.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.